Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

79 trials with published results (8%)

Research Maturity

764 completed trials (82% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.1%

20 terminated out of 935 trials

Success Rate

97.4%

+10.9% vs benchmark

Late-Stage Pipeline

2%

23 trials in Phase 3/4

Results Transparency

10%

79 of 764 completed with results

Key Signals

79 with results97% success20 terminated

Data Visualizations

Phase Distribution

869Total
Not Applicable (180)
Early P 1 (12)
P 1 (640)
P 2 (14)
P 3 (11)
P 4 (12)

Trial Status

Completed764
Unknown65
Recruiting42
Terminated20
Not Yet Recruiting14
Active Not Recruiting13

Trial Success Rate

97.4%

Benchmark: 86.5%

Based on 764 completed trials

Clinical Trials (935)

Showing 20 of 20 trials
NCT01568697Recruiting

Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)

NCT05926362Suspended

Capillary-Venous Paired Data Collection

NCT07395609Not ApplicableNot Yet Recruiting

High Frequency Stimulation to Improve Cognition, Mobility, and Affect in Individuals With and Without Subjective Cognitive Decline

NCT06818032Not ApplicableCompleted

Avocado and Postprandial Responses

NCT07470125Phase 1CompletedPrimary

Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers

NCT05685108Not ApplicableRecruitingPrimary

Optimizing Ultrasound-induced Anti-inflammation in Human Subjects

NCT00761631Phase 3CompletedPrimary

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years

NCT02610465CompletedPrimary

High Image Matrix CT Reconstruction

NCT02417714RecruitingPrimary

Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)

NCT00001258CompletedPrimary

Studies of Frontal Lobe Brain Functioning in Schizophrenia

NCT07301723Phase 1CompletedPrimary

A Trial to Evaluate the Absolute Bioavailability of Cenerimod in Healthy Male Participants

NCT07691957Not ApplicableRecruiting

Microneurography and Intraneural Microstimulation for Upper Limb Sensory Investigation in Healthy and Amputee Subjects

NCT07043283Phase 1CompletedPrimary

A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjects

NCT06342713Phase 1Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT07059858Recruiting

Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities

NCT07415759Not ApplicableRecruitingPrimary

Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes

NCT07241910Phase 1RecruitingPrimary

A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061

NCT07612969Not ApplicableCompleted

Comparing The Effect of Proprioceptive Neuromuscular Facilitation (PNF) When Coupled With Dry Needling (DN), Acupuncture (AN) or Sham Needling (SN) on Knee Range of Motion (ROM), Jump Height and Unipedal Balance

NCT07615699Not Yet Recruiting

Morpho-functional Evaluation of the Retina and Choroid Using Multimodal Imaging in Healthy Subjects and Patients With Retino-choroidal Diseases

NCT07588906Phase 1CompletedPrimary

To Compare the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability Between SHR-3167 Injection and Glargine Insulin in Healthy Subjects

Scroll to load more

Research Network

Activity Timeline